Published in Menopause on September 01, 2013
Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause (2015) 1.17
A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep. Sleep (2013) 0.94
Magnitude of the impact of hot flashes on sleep in perimenopausal women. Fertil Steril (2014) 0.91
The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women. J Clin Endocrinol Metab (2013) 0.84
Interaction between reproductive hormones and physiological sleep in women. J Clin Endocrinol Metab (2015) 0.82
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause. Menopause (2015) 0.80
Insomnia in women approaching menopause: Beyond perception. Psychoneuroendocrinology (2015) 0.79
Hot flashes and sleep: pieces of the puzzle. Menopause (2013) 0.77
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand (1986) 4.12
The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev (2011) 3.59
Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause (2003) 3.57
Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry (2004) 3.13
Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep (2003) 2.60
Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem (2003) 2.38
Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep (2008) 2.37
Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation. Menopause (2009) 2.36
Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology (1989) 2.34
Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med (2006) 2.22
Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (2008) 2.22
Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause (1999) 2.10
Sleep disturbance in menopause. Menopause (2007) 1.94
Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause (2002) 1.92
Emotional antecedents of hot flashes during daily life. Psychosom Med (2005) 1.77
Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry (2010) 1.73
Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril (1998) 1.67
Severe hot flashes are associated with chronic insomnia. Arch Intern Med (2006) 1.67
Daily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women. Menopause (2010) 1.65
Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause (2012) 1.65
Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause (2004) 1.54
Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab (1999) 1.52
Gadgets for measuring hot flashes: have they become the gold standard? J Support Oncol (2009) 1.44
Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas (2005) 1.33
Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med (2006) 1.31
Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep (2010) 1.26
Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments? Breast Cancer Res Treat (2001) 1.25
Lack of sleep disturbance from menopausal hot flashes. Fertil Steril (2004) 1.24
Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause (2009) 1.23
Subjective perception of sleep, but not its objective quality, is associated with immediate postpartum mood disturbances in healthy women. Sleep (2010) 1.21
The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage (2004) 1.20
Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1992) 1.17
More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol Int (2000) 1.14
Association of waking episodes with menopausal hot flushes. JAMA (1981) 1.09
Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab (2003) 1.05
Perceived poor sleep quality in the absence of polysomnographic sleep disturbance in women with severe premenstrual syndrome. J Sleep Res (2012) 1.04
The thermoregulatory effects of menopausal hot flashes on sleep. Sleep (1994) 1.04
Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause (2012) 1.03
Core body temperature during menopausal hot flushes. Fertil Steril (1996) 1.02
Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil Steril (1988) 1.01
Sleep patterns and stability in perimenopausal women. Sleep (1988) 1.01
A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril (1992) 1.00
Cortical activation during menopausal hot flashes. Fertil Steril (2006) 0.98
Sleep, breathing, and menopause: the effect of fluctuating estrogen and progesterone on sleep and breathing in women. Gend Med (2005) 0.96
Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab (2011) 0.96
Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist. J Clin Endocrinol Metab (1983) 0.94
Nightly analyses of subjective and objective (actigraphy) measures of sleep in fibromyalgia syndrome: what accounts for the discrepancy? Clin J Pain (2011) 0.91
A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res (2000) 0.91
Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue. Clin Endocrinol (Oxf) (1987) 0.87
Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women. Fertil Steril (1995) 0.86
An investigation of discordance between subjective and physiological measures of vasomotor symptoms. Climacteric (2010) 0.86
Determination of oestradiol-17 beta in human serum by isotope dilution-mass spectrometry. Definitive methods in clinical chemistry, II. J Clin Chem Clin Biochem (1984) 0.85
Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol (2001) 0.84
Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis. Curr Med Res Opin (2009) 0.80
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
Obstructive sleep apnoea. Lancet (2002) 6.37
A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11
Correlates of long sleep duration. Sleep (2006) 5.67
Association between reduced sleep and weight gain in women. Am J Epidemiol (2006) 4.59
History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22
Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med (2013) 3.98
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol (2009) 3.63
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest (2007) 3.20
Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med (2003) 2.95
Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med (2004) 2.70
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest (2008) 2.69
TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab (2010) 2.50
Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med (2005) 2.35
Retracted Anatomic and physiologic predictors of apnea severity in morbidly obese subjects. Sleep (2003) 2.34
A simplified method for determining phenotypic traits in patients with obstructive sleep apnea. J Appl Physiol (1985) (2013) 2.27
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab (2012) 2.25
Sleep disorders, health, and safety in police officers. JAMA (2011) 2.16
Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci U S A (2010) 2.10
Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond) (2011) 2.08
A method for measuring and modeling the physiological traits causing obstructive sleep apnea. J Appl Physiol (1985) (2011) 2.01
Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause (2002) 1.92
Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med (2014) 1.91
Effect of oxygen in obstructive sleep apnea: role of loop gain. Respir Physiol Neurobiol (2008) 1.90
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A (2006) 1.87
Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J Physiol (2012) 1.85
Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea. Am J Respir Crit Care Med (2014) 1.83
Neurogenic changes in the upper airway of patients with obstructive sleep apnea. Am J Respir Crit Care Med (2011) 1.77
Using a wrist-worn device based on peripheral arterial tonometry to diagnose obstructive sleep apnea: in-laboratory and ambulatory validation. Sleep (2004) 1.75
The male predisposition to pharyngeal collapse: importance of airway length. Am J Respir Crit Care Med (2002) 1.70
Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med (2006) 1.68
Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause (2009) 1.67
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J (2005) 1.67
The influence of lung volume on pharyngeal mechanics, collapsibility, and genioglossus muscle activation during sleep. Sleep (2003) 1.64
Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep (2004) 1.62
Genioglossus muscle responsiveness to chemical and mechanical stimuli during non-rapid eye movement sleep. Am J Respir Crit Care Med (2002) 1.60
Mechanisms used to restore ventilation after partial upper airway collapse during sleep in humans. Thorax (2007) 1.58
Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause (2011) 1.56
Aging influences on pharyngeal anatomy and physiology: the predisposition to pharyngeal collapse. Am J Med (2006) 1.56
Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med (2013) 1.56
The influence of aging on pharyngeal collapsibility during sleep. Chest (2007) 1.55
Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea. Sleep (2009) 1.54
The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures. J Clin Sleep Med (2006) 1.52
Tonic and phasic respiratory drives to human genioglossus motoneurons during breathing. J Neurophysiol (2005) 1.51
The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility. J Appl Physiol (1985) (2009) 1.48
The influence of gender and upper airway resistance on the ventilatory response to arousal in obstructive sleep apnoea in humans. J Physiol (2004) 1.47
Termination of respiratory events with and without cortical arousal in obstructive sleep apnea. Am J Respir Crit Care Med (2011) 1.46
A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patients. Sleep (2004) 1.42
Assessment of a wrist-worn device in the detection of obstructive sleep apnea. Sleep Med (2003) 1.42
Interrater reliability of drug-induced sleep endoscopy. Arch Otolaryngol Head Neck Surg (2010) 1.39
Continuous positive airway pressure versus the mandibular advancing splint: are they equally effective in obstructive sleep apnea management? Am J Respir Crit Care Med (2013) 1.38
The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med (2008) 1.37
Respiratory control stability and upper airway collapsibility in men and women with obstructive sleep apnea. J Appl Physiol (1985) (2005) 1.37
Serotonin receptor subtypes required for ventilatory long-term facilitation and its enhancement after chronic intermittent hypoxia in awake rats. Am J Physiol Regul Integr Comp Physiol (2003) 1.36
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause (2012) 1.35
Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care (2013) 1.34
Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol (2013) 1.34
Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause (2007) 1.34
Genioglossus activity during sleep in normal control subjects and children with obstructive sleep apnea. Am J Respir Crit Care Med (2004) 1.33
The effect of sleep onset on upper airway muscle activity in patients with sleep apnoea versus controls. J Physiol (2005) 1.31
Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab (2006) 1.30
Postural effects on pharyngeal protective reflex mechanisms. Sleep (2004) 1.30
Chronic intermittent hypoxia enhances ventilatory long-term facilitation in awake rats. J Appl Physiol (1985) (2003) 1.29
Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol (2009) 1.29
Neural drive to human genioglossus in obstructive sleep apnoea. J Physiol (2007) 1.28
Genioglossus premotoneurons and the negative pressure reflex in rats. J Physiol (2006) 1.28
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet (2013) 1.26
Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A (2011) 1.26
Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med (2006) 1.25
Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab (2004) 1.25
Assessment of automated scoring of polysomnographic recordings in a population with suspected sleep-disordered breathing. Sleep (2004) 1.24
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Mol Cancer Ther (2004) 1.24
Sensorimotor function of the upper-airway muscles and respiratory sensory processing in untreated obstructive sleep apnea. J Appl Physiol (1985) (2011) 1.24
Pharyngeal pressure and flow effects on genioglossus activation in normal subjects. Am J Respir Crit Care Med (2002) 1.24
A genetic basis for functional hypothalamic amenorrhea. N Engl J Med (2011) 1.24
Genioglossal muscle response to CO2 stimulation during NREM sleep. Sleep (2006) 1.21
The influence of obstructive sleep apnea and gender on genioglossus activity during rapid eye movement sleep. Chest (2008) 1.21
Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol (2007) 1.20
Effect of hypoxic episode number and severity on ventilatory long-term facilitation in awake rats. J Appl Physiol (1985) (2002) 1.20
Discharge patterns of human genioglossus motor units during sleep onset. Sleep (2008) 1.16
Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab (2011) 1.16
Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN). J Clin Endocrinol Metab (2012) 1.15
Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea. Sleep (2013) 1.15
Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric (2012) 1.14
Follow-up assessment of CPAP efficacy in patients with obstructive sleep apnea using an ambulatory device based on peripheral arterial tonometry. Sleep Breath (2006) 1.14
Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology (2007) 1.13
Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab (2013) 1.13
Influence of wakefulness on pharyngeal airway muscle activity. Thorax (2007) 1.12
Phrenic long-term facilitation requires NMDA receptors in the phrenic motonucleus in rats. J Physiol (2005) 1.12
Within-breath control of genioglossal muscle activation in humans: effect of sleep-wake state. J Physiol (2003) 1.11
Air leak during CPAP titration as a risk factor for central apnea. J Clin Sleep Med (2013) 1.10
Classifying menopause stage by menstrual calendars and annual interviews: need for improved questionnaires. Menopause (2013) 1.10
The effect of increased genioglossus activity and end-expiratory lung volume on pharyngeal collapse. J Appl Physiol (1985) (2010) 1.09
Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab (2013) 1.09